US researchers have reported that inhibitors of certain small RNA molecules known as microRNAs can promote an increase in high density lipoprotein cholesterol, thereby reducing the risk of heart disease. The research has been published in Nature.
US researchers have reported that inhibitors of certain small RNA molecules known as microRNAs can promote an increase in high density lipoprotein cholesterol, thereby reducing the risk of heart disease. The research has been published in Nature.